Metformin: taking away the candy for cancer?

M Jalving, JA Gietema, JD Lefrandt, S de Jong… - European journal of …, 2010 - Elsevier
Metformin is widely used in the treatment of diabetes mellitus type 2 where it reduces insulin
resistance and diabetes-related morbidity and mortality. Population-based studies show that …

Physiological approach to assessment of acid–base disturbances

K Berend, APJ de Vries, ROB Gans - New England Journal of …, 2014 - Mass Medical Soc
Physiological Approach to Assessment of Acid–Base Disturbances | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Chloride: the queen of electrolytes?

K Berend, LH Van Hulsteijn, ROB Gans - European journal of internal …, 2012 - Elsevier
BACKGROUND: Channelopathies, defined as diseases that are caused by mutations in
genes encoding ion channels, are associated with a wide variety of symptoms and have …

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population

HL Hillege, V Fidler, GFH Diercks, WH van Gilst… - Circulation, 2002 - Am Heart Assoc
Background—For the general population, the clinical relevance of an increased urinary
albumin excretion rate is still debated. Therefore, we examined the relationship between …

Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects

A Roos, SJL Bakker, TP Links… - The Journal of …, 2007 - academic.oup.com
Context: Thyroid disease and the metabolic syndrome are both associated with
cardiovascular disease. Objective: The aim of this study was to explore the hypothesis that …

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

GWD Landman, N Kleefstra, KJJ van Hateren… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE Several studies have suggested an association between specific diabetes
treatment and cancer mortality. We studied the association between metformin use and …

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients

R Meerwaldt, JWL Hartog, R Graaff… - Journal of the …, 2005 - journals.lww.com
Tissue advanced glycation end products (AGE) are a measure of cumulative metabolic
stress and trigger cytokines driven inflammatory reactions. AGE are thought to contribute to …

Skin autofluorescence is a strong predictor of cardiac mortality in diabetes

R Meerwaldt, HL Lutgers, TP Links, R Graaff… - Diabetes …, 2007 - Am Diabetes Assoc
OBJECTIVE—Advanced glycation end products (AGEs) are biomarkers of metabolic stress
and are thought to contribute to the increase of coronary heart disease (CHD) in diabetes …

Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes

HL Lutgers, R Graaff, TP Links… - Diabetes …, 2006 - Am Diabetes Assoc
OBJECTIVE—Advanced glycation end products (AGEs) are thought to have a role in the
pathogenesis of diabetes complications. We recently reported the association between skin …

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial

ICC van der Horst, F Zijlstra, AWJ van't Hof… - Journal of the American …, 2003 - jacc.org
Objectives: In this study we considered the question of whether adjunction of glucose-insulin-
potassium (GIK) infusion to primary coronary transluminal angioplasty (PTCA) is effective in …